• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌术后患者的生存预测模型

Survival prediction model for postoperative hepatocellular carcinoma patients.

作者信息

Ren Zhihui, He Shasha, Fan Xiaotang, He Fangping, Sang Wei, Bao Yongxing, Ren Weixin, Zhao Jinming, Ji Xuewen, Wen Hao

机构信息

Clinical Medicine Research Institute Department of Hepatology Department of Pathology Cancer Center Department of Interventional Radiology Department of Laparoscopic Surgery of Liver Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.

出版信息

Medicine (Baltimore). 2017 Sep;96(37):e7902. doi: 10.1097/MD.0000000000007902.

DOI:10.1097/MD.0000000000007902
PMID:28906371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5604640/
Abstract

This study is to establish a predictive index (PI) model of 5-year survival rate for patients with hepatocellular carcinoma (HCC) after radical resection and to evaluate its prediction sensitivity, specificity, and accuracy.Patients underwent HCC surgical resection were enrolled and randomly divided into prediction model group (101 patients) and model evaluation group (100 patients). Cox regression model was used for univariate and multivariate survival analysis. A PI model was established based on multivariate analysis and receiver operating characteristic (ROC) curve was drawn accordingly. The area under ROC (AUROC) and PI cutoff value was identified.Multiple Cox regression analysis of prediction model group showed that neutrophil to lymphocyte ratio, histological grade, microvascular invasion, positive resection margin, number of tumor, and postoperative transcatheter arterial chemoembolization treatment were the independent predictors for the 5-year survival rate for HCC patients. The model was PI = 0.377 × NLR + 0.554 × HG + 0.927 × PRM + 0.778 × MVI + 0.740 × NT - 0.831 × transcatheter arterial chemoembolization (TACE). In the prediction model group, AUROC was 0.832 and the PI cutoff value was 3.38. The sensitivity, specificity, and accuracy were 78.0%, 80%, and 79.2%, respectively. In model evaluation group, AUROC was 0.822, and the PI cutoff value was well corresponded to the prediction model group with sensitivity, specificity, and accuracy of 85.0%, 83.3%, and 84.0%, respectively.The PI model can quantify the mortality risk of hepatitis B related HCC with high sensitivity, specificity, and accuracy.

摘要

本研究旨在建立肝细胞癌(HCC)患者根治性切除术后5年生存率的预测指数(PI)模型,并评估其预测敏感性、特异性和准确性。纳入接受HCC手术切除的患者,并随机分为预测模型组(101例患者)和模型评估组(100例患者)。采用Cox回归模型进行单因素和多因素生存分析。基于多因素分析建立PI模型,并据此绘制受试者工作特征(ROC)曲线。确定ROC曲线下面积(AUROC)和PI临界值。预测模型组的多因素Cox回归分析显示,中性粒细胞与淋巴细胞比值、组织学分级、微血管侵犯、手术切缘阳性、肿瘤数量和术后经动脉化疗栓塞治疗是HCC患者5年生存率的独立预测因素。该模型为PI = 0.377×中性粒细胞与淋巴细胞比值 + 0.554×组织学分级 + 0.927×手术切缘阳性 + 0.778×微血管侵犯 + 0.740×肿瘤数量 - 0.831×经动脉化疗栓塞(TACE)。在预测模型组中,AUROC为0.832,PI临界值为3.38。敏感性、特异性和准确性分别为78.0%、80%和79.2%。在模型评估组中,AUROC为0.822,PI临界值与预测模型组吻合良好,敏感性、特异性和准确性分别为85.0%、83.3%和84.0%。PI模型能够以高敏感性、特异性和准确性量化乙型肝炎相关HCC的死亡风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/5604640/1a943994b806/medi-96-e7902-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/5604640/2544366ef531/medi-96-e7902-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/5604640/1a943994b806/medi-96-e7902-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/5604640/2544366ef531/medi-96-e7902-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/5604640/1a943994b806/medi-96-e7902-g006.jpg

相似文献

1
Survival prediction model for postoperative hepatocellular carcinoma patients.肝细胞癌术后患者的生存预测模型
Medicine (Baltimore). 2017 Sep;96(37):e7902. doi: 10.1097/MD.0000000000007902.
2
Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy.预防性经动脉化疗栓塞术对肝癌患者肝切除术后5年生存率的影响。
Oncol Lett. 2019 Aug;18(2):1824-1830. doi: 10.3892/ol.2019.10517. Epub 2019 Jun 21.
3
[Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].[肝癌根治性肝切除术后中性粒细胞与淋巴细胞比值与复发及预后的相关性]
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):365-371. doi: 10.3760/cma.j.issn.0253-3766.2018.05.009.
4
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.术后辅助经导管动脉化疗栓塞治疗伴微血管侵犯的肝细胞癌患者的疗效。
World J Gastroenterol. 2017 Nov 7;23(41):7415-7424. doi: 10.3748/wjg.v23.i41.7415.
5
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
6
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.经导管动脉化疗栓塞术对肝细胞癌术后辅助治疗的临床疗效
World J Surg Oncol. 2016 Apr 2;14:100. doi: 10.1186/s12957-016-0855-z.
7
Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.γ-谷氨酰转肽酶与淋巴细胞比值对伴微血管侵犯的肝细胞癌患者的预测价值。
BMC Cancer. 2020 Feb 18;20(1):132. doi: 10.1186/s12885-020-6628-7.
8
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.在选择乙型肝炎病毒相关肝细胞癌肝移植候选者方面,将杭州标准与中性粒细胞与淋巴细胞比值相结合优于其他标准。
Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):588-95. doi: 10.1016/s1499-3872(15)60416-7.
9
Establishment and validation of a prognostic model for hepatocellular carcinoma after radical liver resection.根治性肝切除术后肝细胞癌预后模型的建立与验证
J BUON. 2019 Jul-Aug;24(4):1420-1428.
10
Mortality predicted accuracy for hepatocellular carcinoma patients with hepatic resection using artificial neural network.使用人工神经网络预测肝细胞癌肝切除患者的死亡率准确性。
ScientificWorldJournal. 2013 Apr 30;2013:201976. doi: 10.1155/2013/201976. Print 2013.

引用本文的文献

1
Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.开发并验证肝癌部分肝切除术后生存预测的列线图。
BMC Surg. 2023 Jan 30;23(1):27. doi: 10.1186/s12893-023-01922-x.
2
Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma.构建并验证用于预测早中期肝癌中老年患者癌症特异性生存的列线图
Front Public Health. 2022 Feb 28;10:848716. doi: 10.3389/fpubh.2022.848716. eCollection 2022.
3
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.

本文引用的文献

1
[Analysis of risk factors of recurrence of hepatocellular carcinoma after control of surgical-risk-factors].
Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):629-34.
2
The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size.组织学分化程度对直径2厘米及以下肝细胞癌肝切除术后结局的影响。
World J Surg. 2015 May;39(5):1134-41. doi: 10.1007/s00268-014-2806-6.
3
[Clinicopathological and prognostic analysis of primary clear cell carcinoma of the liver].[肝脏原发性透明细胞癌的临床病理及预后分析]
基于 SEER 数据库的老年早期肝细胞癌患者癌症特异性生存的网络预测模型研究。
Front Public Health. 2022 Jan 13;9:789026. doi: 10.3389/fpubh.2021.789026. eCollection 2021.
4
A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.用于预测早期肝细胞癌患者癌症特异性生存的实用列线图和风险分层系统。
Cancer Med. 2021 Jan;10(2):496-506. doi: 10.1002/cam4.3613. Epub 2020 Dec 6.
5
Long Noncoding RNAs Coregulated by Annexin A7 and JNK in Hepatocellular Carcinoma Cells Identified by Whole-Genome Expression Profiling.全基因组表达谱分析鉴定的 Annexin A7 和 JNK 共同调控的肝癌细胞中的长非编码 RNA。
Biomed Res Int. 2020 Jul 25;2020:5747923. doi: 10.1155/2020/5747923. eCollection 2020.
6
A Simple-to-Use Nomogram for Predicting the Survival of Early Hepatocellular Carcinoma Patients.一种用于预测早期肝细胞癌患者生存率的简易列线图。
Front Oncol. 2019 Jul 10;9:584. doi: 10.3389/fonc.2019.00584. eCollection 2019.
7
Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma: correlation with microvascular invasion and histologic grade.肝细胞癌的扩散峰度成像(DKI):与微血管侵犯及组织学分级的相关性
Quant Imaging Med Surg. 2019 Apr;9(4):590-602. doi: 10.21037/qims.2019.02.14.
8
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.基础肝脏疾病和晚期肝癌与中性粒细胞-淋巴细胞比值升高有关。
Clin Mol Hepatol. 2019 Sep;25(3):305-316. doi: 10.3350/cmh.2019.0004. Epub 2019 Apr 19.
Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):140-3. doi: 10.3760/cma.j.issn.0253-3766.2013.02.015.
4
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.基于炎症的预后指数预测肝癌经动脉化疗栓塞后的生存优势。
Transl Res. 2012 Aug;160(2):146-52. doi: 10.1016/j.trsl.2012.01.011. Epub 2012 Jan 30.
5
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.经动脉化疗栓塞术联合索拉非尼:治疗 HCV 相关中期肝细胞癌的序贯治疗方案:一项随机临床试验。
Oncologist. 2012;17(3):359-66. doi: 10.1634/theoncologist.2011-0313. Epub 2012 Feb 14.
6
Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification.经动脉化疗栓塞与保守治疗联合用于伴有门静脉癌栓的晚期肝细胞癌:采用新的分类方法。
Med Oncol. 2012 Dec;29(4):2992-7. doi: 10.1007/s12032-011-0145-0. Epub 2011 Dec 27.
7
[Evaluation on short term after hepatectomy for the patients with primary hepatocellular carcinoma].
Zhonghua Wai Ke Za Zhi. 2011 Sep 1;49(9):784-8.
8
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
9
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.经动脉化疗栓塞术可安全应用于侵犯主门静脉的肝细胞癌患者,可能改善总体生存率。
Radiology. 2011 Feb;258(2):627-34. doi: 10.1148/radiol.10101058.
10
[The guideline of prevention and treatment for chronic hepatitis B (2010 version)].《慢性乙型肝炎防治指南(2010年版)》
Zhonghua Gan Zang Bing Za Zhi. 2011 Jan;19(1):13-24. doi: 10.3760/cma.j.issn.1007-3418.2011.01.007.